Haemonetics (HAE) Net Margin (2009 - 2026)

Haemonetics' Net Margin history runs 18 years deep, the most recent figure standing at 5.81% for Q1 2026.

• In Q1 2026, Net Margin fell 2335.0% year-over-year to 5.81%; the TTM figure through Mar 2026 stood at 7.3% (down 503.0% YoY), while the FY2026 annual figure was 7.29%, down 503.0% from the prior year.
• Net Margin was 5.81% for Q1 2026 at Haemonetics, down from 13.21% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 17.54% in Q1 2025 to a low of 5.81% in Q1 2026.
• Historically, Net Margin has averaged 9.3% across 5 years, with a median of 10.19% in 2025.
• The sharpest annual moves came in 2025 and 2026: Net Margin jumped 1159 bps in 2025, then sank 2335 bps in 2026.
• A 5-year view of Net Margin shows it stood at 10.79% in 2022, then dropped by 14 bps to 9.29% in 2023, then gained by 16 bps to 10.76% in 2024, then climbed by 23 bps to 13.21% in 2025, then tumbled by 144 bps to 5.81% in 2026.
• The last three Net Margin figures came in at 5.81% (Q1 2026), 13.21% (Q4 2025), and 11.82% (Q3 2025), per Business Quant data.